Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v4-FR
Language English French
Date Updated 2019-03-07 2019-03-06
Drug Identification Number 00821373 00821373
Brand name COTAZYM ECS 20 COTAZYM ECS 20
Common or Proper name PANCRELIPASE DELAYED-RELEASE CAPSULES PANCRELIPASE DELAYED-RELEASE CAPSULES
Company Name MERCK CANADA INC MERCK CANADA INC
Ingredients AMYLASE PROTEASE LIPASE AMYLASE PROTEASE LIPASE
Strength(s) 100000UNIT 100000UNIT 25000UNIT 100000UNIT 100000UNIT 25000UNIT
Dosage form(s) CAPSULE (DELAYED RELEASE) CAPSULE (DELAYED RELEASE)
Route of administration ORAL ORAL
Packaging size 100' 100'
ATC code A09AA A09AA
ATC description DIGESTIVES, INCL ENZYMES DIGESTIVES, INCL ENZYMES
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-02-25 2019-02-25
Estimated end date 2019-03-06 2019-03-06
Actual end date 2019-03-06 2019-03-06
Shortage status Resolved Actual shortage
Company comments
Health Canada comments